Found 0 matching trials
Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma PHASE1 This phase I/II trial studies the best dose and side effects of venetoclax ...
Show More Location
Multiple Locations
Learn More & Join Trial
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer PHASE1 This is an open-label phase I/II study for patients with advanced (locally ...
Show More Location
Universitätsklinik für Innere Medizin Graz
Learn More & Join Trial
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." PHASE2 This is a phase II, multicenter, open-label study to evaluate the rate of p...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia PHASE2 This phase II trial studies how well pomalidomide, ixazomib citrate, and de...
Show More Learn More & Join Trial
Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia PHASE2 This phase II trial studies the side effects of ibrutinib citrate when give...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma PHASE2 This phase II trial studies how well ixazomib and rituximab work in treatin...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma PHASE1 This phase Ib trial studies the side effects of combination chemotherapy an...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB PHASE1 This is a phase 1, 2-part, open-label study in 4 to 6 pharmacokinetic-evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM) N/A In this study, people with MM will be treated with ixazomib citrate accordi...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. PHASE1 Allogeneic hematopoietic stem cell transplantation (HTC) is the only curati...
Show More Status
Active Not Recruiting
Location
ICO- Hospital Germans Trias i Pujol
Learn More & Join Trial